{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:26:32Z","timestamp":1793647592456,"version":"4.5.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.acuro.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T10:46:05Z","timestamp":1511347565000},"page":"256-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["La incidencia acumulada y los factores predictivos de la cistitis r\u00e1dica en pacientes con c\u00e1ncer de pr\u00f3stata localizado"],"prefix":"10.1016","volume":"42","author":[{"given":"D.","family":"Afonso-Jo\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pacheco-Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Antunes-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vendeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Martins-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2017.06.009_bib0085","series-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.acuro.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5\u2013\u2013A population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.acuro.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.rpor.2013.05.006","article-title":"Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results","volume":"18","author":"Fuentes-Raspall","year":"2013","journal-title":"Rep Pract Oncol Radiother."},{"key":"10.1016\/j.acuro.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.acuro.2017.06.009_bib0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.acuro.2017.06.009_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0970-1591.65380","article-title":"Hemorrhagic cystitis: A challenge to the urologist","volume":"26","author":"Manikandan","year":"2010","journal-title":"Indian J Urol."},{"key":"10.1016\/j.acuro.2017.06.009_bib0115","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s40265-015-0443-5","article-title":"A practical approach to the management of radiation-induced hemorrhagic cystitis","volume":"75","author":"Liem","year":"2015","journal-title":"Drugs."},{"key":"10.1016\/j.acuro.2017.06.009_bib0120","first-page":"199","article-title":"Mechanisms of hemorrhagic cystitis","volume":"2","author":"Haldar","year":"2014","journal-title":"Am J Clin Exp Urol."},{"key":"10.1016\/j.acuro.2017.06.009_bib0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bju.12291","article-title":"Chemical- and radiation-induced haemorrhagic cystitis: Current treatments and challenges","volume":"112","author":"Payne","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2017.06.009_bib0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2011.12.056","article-title":"Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis","volume":"84","author":"Oliai","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.acuro.2017.06.009_bib0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000351331","article-title":"Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria","volume":"91","author":"Liss","year":"2013","journal-title":"Urol Int."},{"key":"10.1016\/j.acuro.2017.06.009_bib0140","first-page":"92","article-title":"A cost-analysis case study of radiation cystitis treatment including hyperbaric oxygen therapy","volume":"42","author":"Smart","year":"2012","journal-title":"Diving Hyperb Med."},{"key":"10.1016\/j.acuro.2017.06.009_bib0145","first-page":"6373","article-title":"Late toxicity rates following definitive radiotherapy for prostate cancer","volume":"19","author":"Ohri","year":"2012","journal-title":"Can J Urol."},{"key":"10.1016\/j.acuro.2017.06.009_bib0150","unstructured":"Radiation Therapy and Oncology Group and the European Organisation for Research and Treatment of Cancer (RTOG\/EORTC). Late Radiation Morbidity Scoring Schema [Online] [consultado 2 Jun 2014]. Disponible en: https:\/\/www.rtog.org\/ResearchAssociates\/AdverseEventReporting\/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx"},{"key":"10.1016\/j.acuro.2017.06.009_bib0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/j.acuro.2017.06.009_bib0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.acuro.2014.12.005","article-title":"Hypofractionated radiation therapy versus conventional radiation therapy in prostate cancer: A systematic review of its safety and efficacy","volume":"39","author":"S\u00e1nchez-G\u00f3mez","year":"2015","journal-title":"Actas Urol Esp"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617302176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617302176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T23:02:13Z","timestamp":1719615733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480617302176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0210480617302176"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2017.06.009","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La incidencia acumulada y los factores predictivos de la cistitis r\u00e1dica en pacientes con c\u00e1ncer de pr\u00f3stata localizado","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}